Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

International Immunology
Y KasaharaN Taniguchi

Abstract

Fas is an apoptosis-signaling receptor important for homeostasis of the immune system. In this study, Fas-mediated apoptosis and Fas mutations were analyzed in three Japanese children from two families with a lymphoproliferative disorder characterized by lymphadenopathy, hepatosplenomegaly, pancytopenia, hypergammaglobulinemia and an increase in TCR alphabeta+ CD4- CD8- T cells. Apoptosis induced by anti-Fas mAb was defective in both activated T cells and B cells, and granulocytes from these patients. Truncated Fas receptor lacking the cytoplasmic death domain caused by a point mutation in the splice region of intron 7 were demonstrated in two siblings. A homozygous point mutation in the splice acceptor of intron 3 was found in the Fas gene of the third patient, which resulted in the skipping of exon 4 and complete loss of Fas expression. Corresponding to these mutations, soluble Fas concentrations were decreased and reciprocally soluble Fas ligands were increased in patients' sera. Interestingly, co-stimulation by immobilized anti-Fas mAb in T cells from the two siblings was comparable to that seen in normal T cells. These results suggest that Fas-mediated apoptosis plays a pivotal role in immunological homeostasis in vivo, es...Continue Reading

Citations

Oct 1, 1998·European Journal of Immunology·K SakataH Dang
Jun 1, 2011·International Journal of Hematology·Keiko NomuraToshio Miyawaki
Sep 5, 2002·Biochemical and Biophysical Research Communications·Takahiro MaedaShimeru Kamihira
Jun 6, 2003·Current Opinion in Immunology·Frédéric Rieux-LaucatFrançoise Le Deist
Dec 7, 2002·Critical Reviews in Oncology/hematology·Hiroshi Wakiguchi
Nov 17, 1999·Scandinavian Journal of Immunology·K SakataH Dang
Aug 24, 1999·Pediatrics International : Official Journal of the Japan Pediatric Society·R NishimuraS Koizumi
Oct 2, 2004·The New England Journal of Medicine·Eliska HolzelovaFrédéric Rieux-Laucat
Jan 5, 2007·Annual Review of Immunology·Hyun Ho ParkHao Wu
Jan 19, 2008·American Journal of Respiratory and Critical Care Medicine·Helen M MarriottDavid H Dockrell
Dec 25, 2010·The Journal of Clinical Investigation·Aude Magerus-ChatinetFrédéric Rieux-Laucat
Feb 2, 1999·The Journal of Clinical Investigation·A K VaishnawK B Elkon
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A MartinM J Lenardo
May 9, 2001·Leukemia & Lymphoma·J Van Der Werff Ten BoschK Thielemans
May 30, 2001·Leukemia & Lymphoma·J van der Werff ten BoschK Thielemans
Aug 4, 2012·The Journal of Allergy and Clinical Immunology·Aude Magerus-ChatinetFrédéric Rieux-Laucat
Jul 5, 2011·Trends in Molecular Medicine·Adrian A LobitoFiona C Kimberley
Apr 23, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Shahid R RandhawaAdrian M Casillas
Apr 22, 2008·Immunology and Allergy Clinics of North America·Helen C Su, Michael J Lenardo
Apr 14, 2006·British Journal of Haematology·Austen WorthH Bobby Gaspar
Oct 26, 2010·Annals of the New York Academy of Sciences·Michael Waterfield, Mark S Anderson
Mar 26, 1999·American Journal of Human Genetics·C E JacksonJ M Puck
Feb 26, 2000·Annual Review of Genetics·S Nagata
Sep 25, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Y ChoiJ M Puck
Sep 22, 2009·Journal of Dental Research·C Y ZhangL H Ge
Dec 29, 2000·Pediatric Clinics of North America·J J BleesingT A Fleisher
Jul 20, 2007·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Samir B KahwashStephen J Qualman
Dec 11, 1999·Current Opinion in Pediatrics·C E Jackson, J M Puck
Mar 26, 2003·Cell Death and Differentiation·F Rieux-LaucatA Fischer
Mar 1, 2003·Paediatric Drugs·Jutte van der Werff ten Bosch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis